Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type (2014-2025) 1.4.2 GLP-2 1.4.3 Growth Hormone 1.4.4 Glutamine 1.4.5 Others 1.5 Market by Application 1.5.1 Global Drugs for Short Bowel Syndrome Market Share by Application (2014-2025) 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Online Pharmacies 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Drugs for Short Bowel Syndrome Market Size 2.2 Drugs for Short Bowel Syndrome Growth Trends by Regions 2.2.1 Drugs for Short Bowel Syndrome Market Size by Regions (2014-2025) 2.2.2 Drugs for Short Bowel Syndrome Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Drugs for Short Bowel Syndrome Market Size by Manufacturers 3.1.1 Global Drugs for Short Bowel Syndrome Revenue by Manufacturers (2014-2019) 3.1.2 Global Drugs for Short Bowel Syndrome Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Drugs for Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI) 3.2 Drugs for Short Bowel Syndrome Key Players Head office and Area Served 3.3 Key Players Drugs for Short Bowel Syndrome Product/Solution/Service 3.4 Date of Enter into Drugs for Short Bowel Syndrome Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Drugs for Short Bowel Syndrome Market Size by Type (2014-2019) 4.2 Global Drugs for Short Bowel Syndrome Market Size by Application (2014-2019) 5 United States 5.1 United States Drugs for Short Bowel Syndrome Market Size (2014-2019) 5.2 Drugs for Short Bowel Syndrome Key Players in United States 5.3 United States Drugs for Short Bowel Syndrome Market Size by Type 5.4 United States Drugs for Short Bowel Syndrome Market Size by Application 6 Europe 6.1 Europe Drugs for Short Bowel Syndrome Market Size (2014-2019) 6.2 Drugs for Short Bowel Syndrome Key Players in Europe 6.3 Europe Drugs for Short Bowel Syndrome Market Size by Type 6.4 Europe Drugs for Short Bowel Syndrome Market Size by Application 7 China 7.1 China Drugs for Short Bowel Syndrome Market Size (2014-2019) 7.2 Drugs for Short Bowel Syndrome Key Players in China 7.3 China Drugs for Short Bowel Syndrome Market Size by Type 7.4 China Drugs for Short Bowel Syndrome Market Size by Application 8 Japan 8.1 Japan Drugs for Short Bowel Syndrome Market Size (2014-2019) 8.2 Drugs for Short Bowel Syndrome Key Players in Japan 8.3 Japan Drugs for Short Bowel Syndrome Market Size by Type 8.4 Japan Drugs for Short Bowel Syndrome Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Drugs for Short Bowel Syndrome Market Size (2014-2019) 9.2 Drugs for Short Bowel Syndrome Key Players in Southeast Asia 9.3 Southeast Asia Drugs for Short Bowel Syndrome Market Size by Type 9.4 Southeast Asia Drugs for Short Bowel Syndrome Market Size by Application 10 India 10.1 India Drugs for Short Bowel Syndrome Market Size (2014-2019) 10.2 Drugs for Short Bowel Syndrome Key Players in India 10.3 India Drugs for Short Bowel Syndrome Market Size by Type 10.4 India Drugs for Short Bowel Syndrome Market Size by Application 11 Central & South America 11.1 Central & South America Drugs for Short Bowel Syndrome Market Size (2014-2019) 11.2 Drugs for Short Bowel Syndrome Key Players in Central & South America 11.3 Central & South America Drugs for Short Bowel Syndrome Market Size by Type 11.4 Central & South America Drugs for Short Bowel Syndrome Market Size by Application 12 International Players Profiles 12.1 Ardelyx 12.1.1 Ardelyx Company Details 12.1.2 Company Description and Business Overview 12.1.3 Drugs for Short Bowel Syndrome Introduction 12.1.4 Ardelyx Revenue in Drugs for Short Bowel Syndrome Business (2014-2019) 12.1.5 Ardelyx Recent Development 12.2 Emmaus Life Sciences 12.2.1 Emmaus Life Sciences Company Details 12.2.2 Company Description and Business Overview 12.2.3 Drugs for Short Bowel Syndrome Introduction 12.2.4 Emmaus Life Sciences Revenue in Drugs for Short Bowel Syndrome Business (2014-2019) 12.2.5 Emmaus Life Sciences Recent Development 12.3 GLyPharma Therapeutic 12.3.1 GLyPharma Therapeutic Company Details 12.3.2 Company Description and Business Overview 12.3.3 Drugs for Short Bowel Syndrome Introduction 12.3.4 GLyPharma Therapeutic Revenue in Drugs for Short Bowel Syndrome Business (2014-2019) 12.3.5 GLyPharma Therapeutic Recent Development 12.4 Merck 12.4.1 Merck Company Details 12.4.2 Company Description and Business Overview 12.4.3 Drugs for Short Bowel Syndrome Introduction 12.4.4 Merck Revenue in Drugs for Short Bowel Syndrome Business (2014-2019) 12.4.5 Merck Recent Development 12.5 Naia Pharmaceuticals 12.5.1 Naia Pharmaceuticals Company Details 12.5.2 Company Description and Business Overview 12.5.3 Drugs for Short Bowel Syndrome Introduction 12.5.4 Naia Pharmaceuticals Revenue in Drugs for Short Bowel Syndrome Business (2014-2019) 12.5.5 Naia Pharmaceuticals Recent Development 12.6 Nutrinia 12.6.1 Nutrinia Company Details 12.6.2 Company Description and Business Overview 12.6.3 Drugs for Short Bowel Syndrome Introduction 12.6.4 Nutrinia Revenue in Drugs for Short Bowel Syndrome Business (2014-2019) 12.6.5 Nutrinia Recent Development 12.7 OxThera 12.7.1 OxThera Company Details 12.7.2 Company Description and Business Overview 12.7.3 Drugs for Short Bowel Syndrome Introduction 12.7.4 OxThera Revenue in Drugs for Short Bowel Syndrome Business (2014-2019) 12.7.5 OxThera Recent Development 12.8 Sancilio & Company 12.8.1 Sancilio & Company Company Details 12.8.2 Company Description and Business Overview 12.8.3 Drugs for Short Bowel Syndrome Introduction 12.8.4 Sancilio & Company Revenue in Drugs for Short Bowel Syndrome Business (2014-2019) 12.8.5 Sancilio & Company Recent Development 12.9 Shire 12.9.1 Shire Company Details 12.9.2 Company Description and Business Overview 12.9.3 Drugs for Short Bowel Syndrome Introduction 12.9.4 Shire Revenue in Drugs for Short Bowel Syndrome Business (2014-2019) 12.9.5 Shire Recent Development 12.10 Zealand Pharma 12.10.1 Zealand Pharma Company Details 12.10.2 Company Description and Business Overview 12.10.3 Drugs for Short Bowel Syndrome Introduction 12.10.4 Zealand Pharma Revenue in Drugs for Short Bowel Syndrome Business (2014-2019) 12.10.5 Zealand Pharma Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Drugs for Short Bowel Syndrome Key Market Segments Table Key Players Drugs for Short Bowel Syndrome Covered Table Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Drugs for Short Bowel Syndrome Market Size Market Share by Type 2014-2025 Figure GLP-2 Figures Table Key Players of GLP-2 Figure Growth Hormone Figures Table Key Players of Growth Hormone Figure Glutamine Figures Table Key Players of Glutamine Figure Others Figures Table Key Players of Others Table Global Drugs for Short Bowel Syndrome Market Size Growth by Application 2014-2025 (Million US$) Figure Hospital Pharmacies Case Studies Figure Retail Pharmacies Case Studies Figure Online Pharmacies Case Studies Figure Drugs for Short Bowel Syndrome Report Years Considered Table Global Drugs for Short Bowel Syndrome Market Size 2014-2025 (Million US$) Figure Global Drugs for Short Bowel Syndrome Market Size and Growth Rate 2014-2025 (Million US$) Table Global Drugs for Short Bowel Syndrome Market Size by Regions 2014-2025 (Million US$) Table Global Drugs for Short Bowel Syndrome Market Size by Regions 2014-2019 (Million US$) Table Global Drugs for Short Bowel Syndrome Market Share by Regions 2014-2019 Figure Global Drugs for Short Bowel Syndrome Market Share by Regions 2014-2019 Figure Global Drugs for Short Bowel Syndrome Market Share by Regions 2019 Table Market Top Trends Table Global Drugs for Short Bowel Syndrome Revenue by Manufacturers (2014-2019) (Million US$) Table Global Drugs for Short Bowel Syndrome Market Share by Manufacturers (2014-2019) Figure Global Drugs for Short Bowel Syndrome Market Share by Manufacturers in 2018 Table Global Drugs for Short Bowel Syndrome Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Drugs for Short Bowel Syndrome Product/Solution/Service Table Date of Enter into Drugs for Short Bowel Syndrome Market Table Mergers & Acquisitions, Expansion Plans Table Global Drugs for Short Bowel Syndrome Market Size by Type (2014-2019) (Million US$) Table Global Drugs for Short Bowel Syndrome Market Size Share by Type (2014-2019) Figure Global Drugs for Short Bowel Syndrome Market Size Market Share by Type (2014-2019) Table Global Drugs for Short Bowel Syndrome Market Size by Application (2014-2019) (Million US$) Table Global Drugs for Short Bowel Syndrome Market Size Share by Application (2014-2019) Figure Global Drugs for Short Bowel Syndrome Market Size Market Share by Application (2014-2019) Figure Global Drugs for Short Bowel Syndrome Revenue Market Share by Application in 2018 Figure United States Drugs for Short Bowel Syndrome Market Size 2014-2019 (Million US$) Table United States Key Players Drugs for Short Bowel Syndrome Revenue (2018-2019) (Million US$) Table United States Key Players Drugs for Short Bowel Syndrome Market Share (2018-2019) Table United States Drugs for Short Bowel Syndrome Market Size by Type (2014-2019) (Million US$) Table United States Drugs for Short Bowel Syndrome Market Share by Type (2014-2019) Table United States Drugs for Short Bowel Syndrome Market Size by Application (2014-2019) (Million US$) Table United States Drugs for Short Bowel Syndrome Market Share by Application (2014-2019) Figure Europe Drugs for Short Bowel Syndrome Market Size 2014-2019 (Million US$) Table Europe Key Players Drugs for Short Bowel Syndrome Revenue (2018-2019) (Million US$) Table Europe Key Players Drugs for Short Bowel Syndrome Market Share (2018-2019) Table Europe Drugs for Short Bowel Syndrome Market Size by Type (2014-2019) (Million US$) Table Europe Drugs for Short Bowel Syndrome Market Share by Type (2014-2019) Table Europe Drugs for Short Bowel Syndrome Market Size by Application (2014-2019) (Million US$) Table Europe Drugs for Short Bowel Syndrome Market Share by Application (2014-2019) Figure China Drugs for Short Bowel Syndrome Market Size 2014-2019 (Million US$) Table China Key Players Drugs for Short Bowel Syndrome Revenue (2018-2019) (Million US$) Table China Key Players Drugs for Short Bowel Syndrome Market Share (2018-2019) Table China Drugs for Short Bowel Syndrome Market Size by Type (2014-20189) (Million US$) Table China Drugs for Short Bowel Syndrome Market Share by Type (2014-2019) Table China Drugs for Short Bowel Syndrome Market Size by Application (2014-2019) (Million US$) Table China Drugs for Short Bowel Syndrome Market Share by Application (2014-2019) Figure Japan Drugs for Short Bowel Syndrome Market Size 2014-2019 (Million US$) Table Japan Key Players Drugs for Short Bowel Syndrome Revenue (2018-2019) (Million US$) Table Japan Key Players Drugs for Short Bowel Syndrome Market Share (2018-2019) Table Japan Drugs for Short Bowel Syndrome Market Size by Type (2014-2019) (Million US$) Table Japan Drugs for Short Bowel Syndrome Market Share by Type (2014-2019) Table Japan Drugs for Short Bowel Syndrome Market Size by Application (2014-2019) (Million US$) Table Japan Drugs for Short Bowel Syndrome Market Share by Application (2014-2019) Figure Southeast Asia Drugs for Short Bowel Syndrome Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Drugs for Short Bowel Syndrome Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Drugs for Short Bowel Syndrome Market Share (2018-2019) Table Southeast Asia Drugs for Short Bowel Syndrome Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Drugs for Short Bowel Syndrome Market Share by Type (2014-2019) Table Southeast Asia Drugs for Short Bowel Syndrome Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Drugs for Short Bowel Syndrome Market Share by Application (2014-2019) Figure India Drugs for Short Bowel Syndrome Market Size 2014-2019 (Million US$) Table India Key Players Drugs for Short Bowel Syndrome Revenue (2018-2019) (Million US$) Table India Key Players Drugs for Short Bowel Syndrome Market Share (2018-2019) Table India Drugs for Short Bowel Syndrome Market Size by Type (2014-2019) (Million US$) Table India Drugs for Short Bowel Syndrome Market Share by Type (2014-2019) Table India Drugs for Short Bowel Syndrome Market Size by Application (2014-2019) (Million US$) Table India Drugs for Short Bowel Syndrome Market Share by Application (2014-2019) Figure Central & South America Drugs for Short Bowel Syndrome Market Size 2014-2019 (Million US$) Table Central & South America Key Players Drugs for Short Bowel Syndrome Revenue (2018-2019) (Million US$) Table Central & South America Key Players Drugs for Short Bowel Syndrome Market Share (2018-2019) Table Central & South America Drugs for Short Bowel Syndrome Market Size by Type (2014-2019) (Million US$) Table Central & South America Drugs for Short Bowel Syndrome Market Share by Type (2014-2019) Table Central & South America Drugs for Short Bowel Syndrome Market Size by Application (2014-2019) (Million US$) Table Central & South America Drugs for Short Bowel Syndrome Market Share by Application (2014-2019) Table Ardelyx Company Details Table Ardelyx Revenue in Drugs for Short Bowel Syndrome Business (2014-2019) (Million US$) Figure Ardelyx Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2014-2019) Table Ardelyx Recent Development Table Emmaus Life Sciences Company Details Table Emmaus Life Sciences Revenue in Drugs for Short Bowel Syndrome Business (2014-2019)(Million US$) Figure Emmaus Life Sciences Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2014-2019) Table Emmaus Life Sciences Recent Development Table GLyPharma Therapeutic Company Details Table GLyPharma Therapeutic Revenue in Drugs for Short Bowel Syndrome Business (2014-2019)(Million US$) Figure GLyPharma Therapeutic Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2014-2019) Table GLyPharma Therapeutic Recent Development Table Merck Company Details Table Merck Revenue in Drugs for Short Bowel Syndrome Business (2014-2019)(Million US$) Figure Merck Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2014-2019) Table Merck Recent Development Table Naia Pharmaceuticals Company Details Table Naia Pharmaceuticals Revenue in Drugs for Short Bowel Syndrome Business (2014-2019)(Million US$) Figure Naia Pharmaceuticals Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2014-2019) Table Naia Pharmaceuticals Recent Development Table Nutrinia Company Details Table Nutrinia Revenue in Drugs for Short Bowel Syndrome Business (2014-2019)(Million US$) Figure Nutrinia Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2014-2019) Table Nutrinia Recent Development Table OxThera Company Details Table OxThera Revenue in Drugs for Short Bowel Syndrome Business (2014-2019)(Million US$) Figure OxThera Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2014-2019) Table OxThera Recent Development Table Sancilio & Company Company Details Table Sancilio & Company Revenue in Drugs for Short Bowel Syndrome Business (2014-2019)(Million US$) Figure Sancilio & Company Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2014-2019) Table Sancilio & Company Recent Development Table Shire Company Details Table Shire Revenue in Drugs for Short Bowel Syndrome Business (2014-2019)(Million US$) Figure Shire Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2014-2019) Table Shire Recent Development Table Zealand Pharma Company Details Table Zealand Pharma Revenue in Drugs for Short Bowel Syndrome Business (2014-2019)(Million US$) Figure Zealand Pharma Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2014-2019) Table Zealand Pharma Recent Development Table Global Drugs for Short Bowel Syndrome Market Size by Regions (Million US$) 2019-2025 Figure Global Drugs for Short Bowel Syndrome Market Size Share by Regions (2019-2025) Figure Global Drugs for Short Bowel Syndrome Market Size Share by Regions in 2025 Figure United States Drugs for Short Bowel Syndrome Market Size Forecast (2019-2025)(Million USD) Figure Europe Drugs for Short Bowel Syndrome Market Size Forecast (2019-2025)(Million USD) Figure China Drugs for Short Bowel Syndrome Market Size Forecast (2019-2025)(Million USD) Figure Japan Drugs for Short Bowel Syndrome Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Drugs for Short Bowel Syndrome Market Size Forecast (2019-2025)(Million USD) Figure India Drugs for Short Bowel Syndrome Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Drugs for Short Bowel Syndrome Market Size Forecast (2019-2025)(Million USD) Table Global Drugs for Short Bowel Syndrome Market Size by Product (2019-2025) (Million US$) Figure Global Drugs for Short Bowel Syndrome Market Size by Product (2019-2025) Figure Global Drugs for Short Bowel Syndrome Market Size by Product in 2025 Table Global Drugs for Short Bowel Syndrome Market Size by Application (2019-2025) (Million US$) Figure Global Drugs for Short Bowel Syndrome Market Size by Application (2019-2025) Figure Global Drugs for Short Bowel Syndrome Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Ardelyx Emmaus Life Sciences GLyPharma Therapeutic Merck Naia Pharmaceuticals Nutrinia OxThera Sancilio & Company Shire Zealand Pharma